Rust GS |
Multicenter comparison of clarithromycin and amoxicillin. |
1994 |
Arch Fam Med |
pmid:7921290
|
Sieber CC et al. |
[Helicobacter pylori resistance against metronidazole in Switzerland: implications for eradication therapy?]. |
1994 |
Schweiz Med Wochenschr |
pmid:8091165
|
Ishida K et al. |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031048
|
Thijs JC et al. |
Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection. |
1994 |
Aliment. Pharmacol. Ther. |
pmid:8186339
|
Honeybourne D et al. |
The levels of clarithromycin and its 14-hydroxy metabolite in the lung. |
1994 |
Eur. Respir. J. |
pmid:7925906
|
Gad A and Unge P |
Antibacterial therapy of Helicobacter pylori-associated peptic ulcer disease: a new strategy. The Swedes go for it. |
1994 |
J. Clin. Gastroenterol. |
pmid:7930437
|
Braegger CP and Nadal D |
Clarithromycin and pseudomembranous enterocolitis. |
1994 |
Lancet |
pmid:7904702
|
Goldman RC et al. |
Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979278
|
Roblin PM et al. |
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979292
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Olliaro P et al. |
In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii. |
1994 |
J. Antimicrob. Chemother. |
pmid:7706160
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Klemens SP and Cynamon MH |
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979271
|
Kanatani MS and Guglielmo BJ |
The new macrolides. Azithromycin and clarithromycin. |
1994 |
West. J. Med. |
pmid:8128699
|
Walker KJ et al. |
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811010
|
Price DA et al. |
Clinical response to the addition of clarithromycin in Pneumocystis carinii pneumonia refractory to high dose co-trimoxazole. |
1994 |
J. Antimicrob. Chemother. |
pmid:7814298
|
Tahara RW et al. |
The question of clarithromycin: a first-line drug for sinusitis? |
1994 |
Arch Fam Med |
pmid:7818657
|
Pustorino S et al. |
[Effects of intravenous administration of clarithromycin on plasma levels of gastrin and group I pepsinogen]. |
1994 |
Clin Ter |
pmid:7820984
|
Alder J et al. |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. |
1994 |
J. Acquir. Immune Defic. Syndr. |
pmid:7932081
|
Ferrari SL et al. |
The interaction between clarithromycin and cyclosporine in kidney transplant recipients. |
1994 |
Transplantation |
pmid:7940695
|